• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2023, Vol. 25 ›› Issue (1): 56-62.DOI: 10.3969/j.issn.1671-2587.2023.01.010

• 血液安全监测专题 • 上一篇    下一篇

2020~2021年全国部分地区采供血不良事件哨点监测情况分析*

代华友, 刘开强, 刘晓杰, 华敏玉, 黄梅, 邱晓珊, 李莉华, 黄霞   

  1. 400015 重庆,重庆市血液中心(代华友,黄霞); 文山州中心血站(刘开强); 秦皇岛市中心血站(刘晓杰); 无锡市红十字中心血站(华敏玉); 绵阳市红十字中心血站(黄梅); 福建省龙岩市中心血站(邱晓珊); 河北省血液中心(李莉华)
  • 收稿日期:2022-10-31 发布日期:2023-02-20
  • 通讯作者: 黄霞,女,主任技师,主要从事血液质量管理和血液安全监测体系建立研究,(E-mail)xiahuangyy@163.com。共同通信作者:李莉华,女,主任技师,主要从事血液质量管理工作,(E-mail)15931096399@163.com。
  • 作者简介:代华友(1983-),男,主管技师,主要从事血液质量管理与控制和血液安全监测工作,(E-mail)57665214@qq.com。并列第一作者:刘开强(1987-),男,主管检验师,主要从事血液质量管理与控制和血液安全监测工作,(E-mail)772137151@qq.com。
  • 基金资助:
    *本课题受重庆市科卫联合医学科研重点项目(No.2022ZDXM031)资助

Analysis of Haemovigilance of Adverse Events in Blood Establishments from 2020 to 2021

DAI Hua-you, LIU Kai-qiang, LIU Xiao-jie, et al   

  1. Chongqing Blood Center, Chongqing 400015
  • Received:2022-10-31 Published:2023-02-20

摘要: 目的 分析中国输血协会血液安全监测专业委员会开展血液安全监测中采供血不良事件的哨点监测情况,探讨采供血不良事件的数据应用与监测工作改进。方法 对2020~2021年各哨点单位报告的采供血不良事件数据进行回顾性分析。结果 2020~2021年的采供血不良事件监测中,血站的哨点单位对不良事件有报告的占比分别为38.71%(24/62)和25.61%(21/82),报告数据的要素填写完整性分析结果显示,仅50%(6/12)的要素符合要求。总体报告数据例数分别为440例和295例,经审阅后纳入采供血不良事件分析的数据分别占27.50%(121/440)和50.85%(150/295),其中,不良事件主要的发生环节为献血者征询和血液采集,分别对疑似有健康隐患的3例和4例献血者进行随访后无健康影响,28.93%(35/121)和30.67%(46/150)的血液成分经判断分析为血液质量受影响而被控制。结论 血液安全监测为血站质量体系的持续改进提供了依据,但采供血不良事件在定义标准、识别处理和数据完整性等方面还需要开展培训并持续优化,以促进血液安全监测工作有效推进。

关键词: 血液安全监测, 采供血不良事件, 血液安全, 不符合项

Abstract: Objective To analyze the haemovigilance of adverse events in blood establishments conducted by the Working Party on Haemovigilance of the Chinese Society of Blood Transfusion, and to investigate improvement of data application and surveillance of adverse events in blood establishments. Methods A retrospective analysis of the data of adverse events in blood establishments reported by sentinels from 2020~2021 was conducted. Results During last two years, the percentages of adverse events reported by sentinels were 38.71% (24/62) and 25.61% (21/82). Analysis of data completeness showed that only 50% (6/12) of the reported data elements were compliant. In total, 440 and 295 cases were reported each year, and the data belonged to the adverse events analysis accounted for 27.50% (121/440) and 50.85% (150/295), respectively. Reported adverse events mainly occurred during donor counselling and blood collection, with 3 and 4 cases of donors suspected with health risk showing no abnormalities in follow-up, and 28.93% (35/121) and 30.67% (46/150) of the reported cases were controlled due to affected blood quality. Conclusion Haemovigilance provides a basis for the continuous improvement of the quality management system in blood establishment. In order to promote haemovigilance, the definition and standards, identification and management, and data integrity of adverse events in blood establishment requires further training and continuous improvement.

Key words: Haemovigilance, Adverse events in blood establishment, Blood safety, Non-conformity

中图分类号: